CIK: 1494695 - Address: 200 Garrett Street, Suite S, Charlottesville, VA 22902
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/26/24 16:15
11/22/24
VRCAVerrica Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsManning Paul BVADTP.d00.00022,92115138,061M
9/16/24 16:05
9/12/24
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsManning Paul BNCDP3,0008.90033756,603I
7/1/24 08:00
6/27/24
TSHATaysha Gene Therapies, Inc.DEHealthBioPrdBiological Products, (No DiagManning Paul BVATP3,0002.2501,333624,851D
12/18/23 17:00
12/14/23
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsManning Paul BNCDP2,0007.16027956,245D
11/20/23 07:35
11/17/23
TSHATaysha Gene Therapies, Inc.DEHealthBioPrdBiological Products, (No DiagManning Paul BVATP1631.630100023,518I
8/16/23 20:57
8/16/23
TSHATaysha Gene Therapies, Inc.DEHealthBioPrdBiological Products, (No DiagManning Paul BVATP14,8200.9000016,46723723,418I
7/24/23 18:47
7/24/23
VRCAVerrica Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsManning Paul BVADTP1,0045.020200115,589D
11/2/22 16:09
10/31/22
TSHATaysha Gene Therapies, Inc.DEHealthBioPrdBiological Products, (No DiagManning Paul BTXDTP3,0002.0001,500286,951D
7/5/22 16:10
7/5/22
VRCAVerrica Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsManning Paul BVADTP10,0002.1004,7624515,389D
4/19/22 16:30
4/18/22
LQDALiquidia CorpDEHealthDrugPharmaceutical PreparationsManning Paul BNCDP2,0005.10039285,530D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact